Related Experiment Video
Updated: Mar 26, 2026
A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Preventing Infections in Sickle Cell Disease: The Unfinished Business
Stephen K Obaro1,2,3,4, P Y Iroh Tam5
1Department of pediatrics, Division of Pediatric Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska.
Abstract:
While encapsulated bacterial agents, particularly Streptococcus pneumoniae, are recognized as important microbes that are associated with serious illness in hosts with sickle cell disease (SCD), multiple pathogens are implicated in infectious manifestations of SCD. Variations in clinical practice have been an obstacle to the universal implementation of infection preventive management through active, targeted vaccination of these individuals and routine usage of antibiotic prophylaxis. Paradoxically, in low-income settings, there is evidence that SCD also increases the risk for several other infections that warrant additional infection preventive measures. The infection preventive care among patients with SCD in developed countries does not easily translate to the adoption of these recommendations globally, which must take into account the local epidemiology of infections, available vaccines and population-specific vaccine efficacy, environment, health care behaviors, and cultural beliefs, as these are all factors that play a complex role in the manifestation of SCD and the prevention of infectious disease morbidity.
Insights
Sickle cell disease (SCD) patients face increased infection risks from multiple pathogens. Tailored, globally adaptable preventive strategies are crucial, considering local factors for effective infection control.
Area of Science:
- Infectious Diseases
- Hematology
- Public Health
Background:
- Patients with sickle cell disease (SCD) are highly susceptible to serious infections, particularly from encapsulated bacteria like Streptococcus pneumoniae.
- Despite recognized risks, variations in clinical practice hinder universal implementation of preventive strategies such as vaccination and antibiotic prophylaxis.
- SCD patients in low-income settings face additional infection risks, necessitating context-specific preventive measures.
Purpose of the Study:
- To highlight the multifaceted infectious disease burden in sickle cell disease.
- To address the challenges in global implementation of infection preventive care for SCD patients.
- To emphasize the need for localized, culturally sensitive preventive strategies.
Main Methods:
- Review of existing literature on infectious complications in sickle cell disease.
- Analysis of factors influencing preventive care adoption in different socioeconomic settings.
- Exploration of epidemiological data and vaccine efficacy in diverse populations.
Main Results:
- Multiple pathogens, beyond encapsulated bacteria, contribute to infectious morbidity in SCD.
- Clinical practice variations and resource limitations impede consistent preventive care.
- Global adoption of preventive strategies requires adaptation to local epidemiology, vaccine availability, and cultural contexts.
Conclusions:
- Effective infection prevention in sickle cell disease necessitates a comprehensive approach that transcends standard protocols.
- Tailoring preventive strategies to local epidemiological, environmental, and cultural factors is essential for global health equity.
- Further research and implementation science are needed to optimize infection prevention for SCD patients worldwide.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
08:23Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry
Published on: November 5, 2019
Related Concept Videos
01:26Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
01:22Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
01:20Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...